219 related articles for article (PubMed ID: 29878688)
1. Comparison of basiliximab vs antithymocyte globulin for induction in pediatric heart transplant recipients: An analysis of the International Society for Heart and Lung Transplantation database.
Butts RJ; Dipchand AI; Sutcliffe D; Bano M; Dimas V; Morrow R; Das B; Kirk R
Pediatr Transplant; 2018 Jun; 22(4):e13190. PubMed ID: 29878688
[TBL] [Abstract][Full Text] [Related]
2. Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab.
Ansari D; Lund LH; Stehlik J; Andersson B; Höglund P; Edwards L; Nilsson J
J Heart Lung Transplant; 2015 Oct; 34(10):1283-91. PubMed ID: 26087667
[TBL] [Abstract][Full Text] [Related]
3. A retrospective comparison of the efficacy and safety in kidney transplant recipients with basiliximab and anti-thymocyte globulin.
Wang W; Yin H; Li XB; Hu XP; Yang XY; Liu H; Ren L; Wang Y; Zhang XD
Chin Med J (Engl); 2012 Mar; 125(6):1135-40. PubMed ID: 22613543
[TBL] [Abstract][Full Text] [Related]
4. Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents.
Whitson BA; Kilic A; Lehman A; Wehr A; Hasan A; Haas G; Hayes D; Sai-Sudhakar CB; Higgins RS
Clin Transplant; 2015 Jan; 29(1):9-17. PubMed ID: 25284138
[TBL] [Abstract][Full Text] [Related]
5. Induction treatment with rabbit antithymocyte globulin versus basiliximab in renal transplant recipients with planned early steroid withdrawal.
Martin ST; Roberts KL; Malek SK; Tullius SG; Vadivel N; De Serres S; Grafals M; Elsanjak A; Filkins BA; Chandraker A; Gabardi S
Pharmacotherapy; 2011 Jun; 31(6):566-73. PubMed ID: 21923440
[TBL] [Abstract][Full Text] [Related]
6. Antithymocyte globulin induction therapy and myocardial complement deposition in pediatric heart transplantation.
Ghaleb S; Wittekind SG; Martinez H; Kasten J; Gao Z; Hengehold T; Chin C
Pediatr Transplant; 2021 Sep; 25(6):e13998. PubMed ID: 33704881
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Basiliximab and Anti-Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis.
Ansari D; Höglund P; Andersson B; Nilsson J
J Am Heart Assoc; 2015 Dec; 5(1):. PubMed ID: 26722127
[TBL] [Abstract][Full Text] [Related]
8. Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy.
Mattei MF; Redonnet M; Gandjbakhch I; Bandini AM; Billes A; Epailly E; Guillemain R; Lelong B; Pol A; Treilhaud M; Vermes E; Dorent R; Lemay D; Blanc AS; Boissonnat P
J Heart Lung Transplant; 2007 Jul; 26(7):693-9. PubMed ID: 17613399
[TBL] [Abstract][Full Text] [Related]
9. Rabbit antithymocyte globulin versus basiliximab in renal transplantation.
Brennan DC; Daller JA; Lake KD; Cibrik D; Del Castillo D;
N Engl J Med; 2006 Nov; 355(19):1967-77. PubMed ID: 17093248
[TBL] [Abstract][Full Text] [Related]
10. Rabbit antithymocyte globulin compared with basiliximab in kidney transplantation: a single-center study.
Kim JM; Jang HR; Kwon CH; Huh WS; Kim GS; Kim SJ; Joh JW; Oh HY
Transplant Proc; 2012 Jan; 44(1):167-70. PubMed ID: 22310606
[TBL] [Abstract][Full Text] [Related]
11. Induction therapy in simultaneous pancreas-kidney transplantation: thymoglobulin versus basiliximab.
Fernández-Burgos I; Montiel Casado MC; Pérez-Daga JA; Aranda-Narváez JM; Sánchez-Pérez B; León-Díaz FJ; Cabello-Díaz M; Rodríguez-Burgos D; Hernández-Marrero D; Santoyo-Santoyo J
Transplant Proc; 2015; 47(1):120-2. PubMed ID: 25645787
[TBL] [Abstract][Full Text] [Related]
12. Comparison of single bolus ATG and Basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen.
Yang SL; Wang D; Wu WZ; Lin WH; Xu TZ; Cai JQ; Tan JM
Transpl Immunol; 2008 Jan; 18(3):281-5. PubMed ID: 18047938
[TBL] [Abstract][Full Text] [Related]
13. Thymoglobulin versus basiliximab induction therapy for simultaneous kidney-pancreas transplantation: impact on rejection, graft function, and long-term outcome.
Bazerbachi F; Selzner M; Boehnert MU; Marquez MA; Norgate A; McGilvray ID; Schiff J; Cattral MS
Transplantation; 2011 Nov; 92(9):1039-43. PubMed ID: 22002345
[TBL] [Abstract][Full Text] [Related]
14. Anti-thymocyte globulin versus basiliximab induction in renal transplant recipients: Long-term outcome.
Kesiraju S; Paritala P; Rao Ch UM; Athmakuri SM; Reddy VS; Sahariah S
Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):9-15. PubMed ID: 24434376
[TBL] [Abstract][Full Text] [Related]
15. Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection.
Sollinger H; Kaplan B; Pescovitz MD; Philosophe B; Roza A; Brayman K; Somberg K
Transplantation; 2001 Dec; 72(12):1915-9. PubMed ID: 11773888
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of ATG vs. Basiliximab induction.
Ulrich F; Niedzwiecki S; Pascher A; Kohler S; Weiss S; Fikatas P; Schumacher G; May G; Reinke P; Neuhaus P; Tullius SG; Pratschke J
Eur J Clin Invest; 2011 Sep; 41(9):971-8. PubMed ID: 21382021
[TBL] [Abstract][Full Text] [Related]
17. Induction immunosuppression strategies and long-term outcomes after heart transplantation.
Nozohoor S; Stehlik J; Lund LH; Ansari D; Andersson B; Nilsson J
Clin Transplant; 2020 Jul; 34(7):e13871. PubMed ID: 32271484
[TBL] [Abstract][Full Text] [Related]
18. A comparative analysis of kidney allograft outcomes in steroid use versus steroid discontinuation after basiliximab and ATG induction: A UNOS database study.
Nissaisorakarn P; Patel H; Cardarelli F; Amtul A
Clin Nephrol; 2024 Jul; 102():39-50. PubMed ID: 38699983
[TBL] [Abstract][Full Text] [Related]
19. Basiliximab or antithymocyte globulin for induction therapy in kidney transplantation: a meta-analysis.
Liu Y; Zhou P; Han M; Xue CB; Hu XP; Li C
Transplant Proc; 2010 Jun; 42(5):1667-70. PubMed ID: 20620496
[TBL] [Abstract][Full Text] [Related]
20. Low-dose RATG with or without basiliximab in renal transplantation: a matched-cohort observational study.
Gentile G; Somma C; Gennarini A; Mastroluca D; Rota G; Lacanna F; Locatelli B; Remuzzi G; Ruggenenti P
Am J Nephrol; 2015; 41(1):16-27. PubMed ID: 25612603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
